1-159171838-A-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM1BP4_ModerateBS2
The NM_001127173.3(CADM3):āc.73A>Cā(p.Asn25His) variant causes a missense change. The variant allele was found at a frequency of 0.00000482 in 1,244,722 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 31)
Exomes š: 0.0000046 ( 0 hom. )
Consequence
CADM3
NM_001127173.3 missense
NM_001127173.3 missense
Scores
3
2
14
Clinical Significance
Conservation
PhyloP100: 4.02
Genes affected
CADM3 (HGNC:17601): (cell adhesion molecule 3) The protein encoded by this gene is a calcium-independent cell-cell adhesion protein that can form homodimers or heterodimers with other nectin proteins. The encoded protein has both homophilic and heterophilic cell-cell adhesion activity. This gene is reported to be a tumor suppressor gene. [provided by RefSeq, Oct 2016]
AIM2 (HGNC:357): (absent in melanoma 2) AIM2 is a member of the IFI20X /IFI16 family. It plays a putative role in tumorigenic reversion and may control cell proliferation. Interferon-gamma induces expression of AIM2. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM1
In a site Not glycosylated (size 0) in uniprot entity CADM3_HUMAN
BP4
Computational evidence support a benign effect (MetaRNN=0.19728032).
BS2
High AC in GnomAdExome4 at 5 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CADM3 | NM_001127173.3 | c.73A>C | p.Asn25His | missense_variant | 1/9 | ENST00000368125.9 | NP_001120645.1 | |
CADM3 | NM_021189.5 | c.73A>C | p.Asn25His | missense_variant | 1/10 | NP_067012.1 | ||
CADM3 | NM_001346510.2 | c.73A>C | p.Asn25His | missense_variant | 1/9 | NP_001333439.1 | ||
CADM3 | XM_024448760.2 | c.73A>C | p.Asn25His | missense_variant | 1/12 | XP_024304528.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CADM3 | ENST00000368125.9 | c.73A>C | p.Asn25His | missense_variant | 1/9 | 1 | NM_001127173.3 | ENSP00000357107 | P2 | |
CADM3 | ENST00000368124.8 | c.73A>C | p.Asn25His | missense_variant | 1/10 | 1 | ENSP00000357106 | A2 | ||
CADM3 | ENST00000416746.1 | c.73A>C | p.Asn25His | missense_variant | 1/7 | 1 | ENSP00000387802 | |||
AIM2 | ENST00000695582.1 | n.33+15973T>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151998Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
151998
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000458 AC: 5AN: 1092724Hom.: 0 Cov.: 31 AF XY: 0.00000387 AC XY: 2AN XY: 517242
GnomAD4 exome
AF:
AC:
5
AN:
1092724
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
517242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151998Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74234
GnomAD4 genome
AF:
AC:
1
AN:
151998
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
74234
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2024 | The c.73A>C (p.N25H) alteration is located in exon 1 (coding exon 1) of the CADM3 gene. This alteration results from a A to C substitution at nucleotide position 73, causing the asparagine (N) at amino acid position 25 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Pathogenic
D;D;D
Sift4G
Pathogenic
D;T;T
Polyphen
P;B;.
Vest4
MutPred
Gain of helix (P = 0.132);Gain of helix (P = 0.132);Gain of helix (P = 0.132);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at